MedtronicTalks

In this interview, Bob White, executive vice President and president of Medtronic’s Medical Surgical Portfolio, explains the importance of corporate culture. He also shares his “Big 5” list of qualities he likes to see in potential hires. We also hear from our sponsor, Foster.

In this episode of the MedtronicTalks podcast, Martha Ha, chief privacy officer and chief counsel of corporate governance, and John de Csepel, CMO, vice president, medical affairs of the Americas, explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture.

Both come to the conversation bringing direct experiences. Ha, who is Korean descent, shares some troubling experiences from her young life and some challenges she's had to overcome and some realizations that she's had. Dr. de Csepel is married to a woman of Chinese descent and he's raising two biracial children.

Ha gives high praise to Medtronic leadership. She also shares that the company also has won external recognition in the form of several awards.

Giovanni Di Napoli, president of Medtronic’s gastrointestinal business, walks us through his path from the basketball court to the medtech industry. In this discussion he shares the company’s vision for delivering less invasive diagnostic and treatment tools to make diagnosis and treatment much easier for patients.

In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X Stealth and Hugo RAS system platforms.

Megan Rosengarten, president of surgical robotics, says HUGO is poised to deliver surgeons newfound capabilities and options. The company hopes to begin selling the system later this year after filing for a CE Mark in Europe and an IDE with the US Food and Drug Administration.

We also speak with Linnea Burman, vice president and general manager, enabling technologies, about Medtronic’s cranial and spinal offerings including the spine surgical robot, Mazor.

Less than a year into his role as CEO, Geoff Martha and the Medtronic leadership has overseen a significant overhaul of medtech’s largest player.

Martha says the company is clearing minor COVID-19 bump and sees an open road for the company to continue to grab share from competitors.

Martha details what products are gaining the most traction while also identifying those that still have some ground to gain.

We also discuss:

-When it may bring its renal denervation project to the FDA

-Why the surgical robotic Hugo system will be worth the wait (and why development has taken more than a decade)

-Whether or not Medtronic will collaborate more with private equity firms, early-stage incubators and maybe even SPACs?

-What will the company’s acquisition strategy look like in 2021. And why.

Why the price-cutting for drug-eluting stents may represent an opportunity for Medtronic’s more innovative products.

In this episode of the MedtronicTalks Podcast, host Tom Salemi speaks with two of the principal architects of Medtronic's move to reduce i's impact on the globe.

Ginny Cassidy, director of the Enterprise Sustainability Program at the company, explains why executives and investors at companies need to understand their TOTAL impact on the environment. She also shares ways Medtronic devices can help others reduce their own impacts.

Nate Pommier, senior environmental, health and safety manager for the EHS Services department, details how changes in packaging and other efforts are making a difference. He also explains why environmental awareness can help draw better talent to the company.

Subscribe to this podcast on major podcast applications.

A year ago, the emerging pandemic brought Medtronic’s respiratory business front-and-center as demands for ventilators shot up to save the lives of thousands of people hit with COVID-19.

In this interview, the first of the MedtronicTalks Podcast Series, Medtronic’s Ariel Mactavish and Dr. John de Csepel detail how Medtronic answered the call in many ways.

MacTavish, president of the company’s Respiratory Interventions Operating Unit at Medtronic, said Medtronic quickly realize they couldn’t work alone. “We scaled as rapidly as possible internally with our own manufacturing facilities, but we also worked with partners to try to expand different areas of by sharing our ventilation IP, allowing others to manufacture it, giving good advice to others, to try to ramp that up,” she says in this interview.

Meanwhile, Dr. Csepel, chief medical officer and vice president of medical affairs of Medtronic’s Americas region, recalled his own experiences in the New York City hospital where he serves as a general surgeon on weekends. “What I saw there was a transformation like I hope I never see again for the rest of my life,” de Csepel said, recalling that the hospital had to set up several ICUs that he had a hand in running. de Csepel drew on that experience to help formulate Medtronic’s response to the pandemic, including developing a plan to care for employees.

Hear how Medtronic is taking lessons learned from last year to guide respiratory interventions going forward.